HCR 96

  • Louisiana House Concurrent Resolution
  • 2024 Regular Session
  • Introduced in House
  • Passed House May 22, 2024
  • Senate
  • Governor

INSURANCE/HEALTH: Requests the Department of Insurance to study the impact of alternative funding programs on patient access to affordable prescription drugs

Votes


Actions


Jun 04, 2024

House

Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.

Jun 02, 2024

Senate

Signed by the President of the Senate.

May 31, 2024

House

Enrolled and signed by the Speaker of the House.

May 30, 2024

House

Received from the Senate without amendments.

May 29, 2024

Senate

Read by title and concurred in by a vote of 24 yeas and 0 nays. Ordered returned to the House.

Senate

Rules suspended. Recalled from Committee.

May 23, 2024

Senate

Read second time by title and referred to the Committee on Insurance.

May 22, 2024

Senate

Received in the Senate. Read first time by title and placed on the Calendar for a second reading.

House

Read by title, roll called on final consideration, yeas 98, nays 0. The resolution was adopted and ordered to the Senate.

House

Called from the calendar.

House

Rules suspended.

May 20, 2024

House

Read by title, amended, ordered engrossed, passed to 3rd reading.

May 15, 2024

House

Reported with amendments (15-0).

May 06, 2024

House

Read by title, under the rules, referred to the Committee on Insurance.

May 01, 2024

House

Read by title. Lies over under the rules.

Bill Text

Bill Text Versions Format
HCR96 Enrolled PDF
HCR96 Engrossed PDF
HCR96 Original PDF
House Committee Amendment, #4686, INS, Adopted PDF
House Committee Amendment, #1078, INS, Draft PDF

Related Documents

Document Format
Digest of HCR96 Original PDF
Digest of HCR96 Engrossed PDF
Resume Digest for HCR96 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Louisiana Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.